Search
Selected Filter
Displaying 261–270 of 305 research results
-
ARVO 2014: European Collaboration Developing Cross-Cutting, Vision-Saving Therapies
Eye On the Cure Research NewsSimply put, they’re creating therapies that can save vision in as many people as possible, independent of the genetic cause of disease.
-
Total Blindness and Non-24 Sleep Disorder
Eye On the Cure Research NewsNon-24 is a very rare condition affecting many (but not all) people who are totally blind and have absolutely no light perception. Their circadian clocks become out of sync as a result.
-
UCI Stem-Cell Pioneer Poised to Launch Clinical Trial for RP Patients
Eye On the Cure Research NewsDr. Henry Klassen’s progenitor-based therapy has the potential to rescue a variety of retinal cells — including rods, cones, retinal pigment epithelium and ganglion cells — and, therefore, may save vision in people with a wide range of conditions.
-
The Power of Suggestion — Challenges of the Placebo Effect
Science EducationEven in a well-designed clinical trial, the placebo effect can rear its head.
-
Choroideremia Gene Therapy Improves Vision in Human Study
Eye On the Cure Research NewsResearchers were able to improve vision in five of six people with choroideremia participating in a clinical trial.
-
Nouvelle Lumière: French Bionic Retina in a Human Study
Eye On the Cure Research NewsThe French retinal implant developer Pixium quietly launched a clinical trial for its Intelligent Retinal Implant System 1 (IRIS1) in France, Austria and Germany.
-
Is Acupuncture a Beneficial Treatment for Retinitis Pigmentosa?
Eye On the Cure Research NewsAcupuncture definitely has potential benefits, and the breadth of those is being aggressively explored.
-
Urine Test Helps Diagnose RP Caused by DHDDS Mutations
Eye On the Cure Research NewsWhile it isn’t a substitute for a diagnosis through genetic testing, the urine test can verify that a given DHDDS mutation is, in fact, causing RP.
-
New Imaging Technique May Be Game-Changer for RP Clinical Trials
Eye On the Cure Research NewsKnown as EZ Width, it holds potential for reducing the time, cost and number of patients needed to determine if a therapy is working in a clinical trial.
